Global Eosinophilic Esophagitis Drug Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2031

Report ID: 953521 | Published Date: Jan 2025 | No. of Page: 129 | Base Year: 2024 | Rating: 3.9 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Eosinophilic Esophagitis Drug Product Introduction
    1.2 Market by Type
        1.2.1 Global Eosinophilic Esophagitis Drug Market Size Growth Rate by Type
        1.2.2 Budesonide
        1.2.3 Fluticasone
        1.2.4 Others
    1.3 Market by Application
        1.3.1 Global Eosinophilic Esophagitis Drug Market Size Growth Rate by Application
        1.3.2 Hospitals
        1.3.3 Clinics
        1.3.4 Drugstore
    1.4 Study Objectives
    1.5 Years Considered

2 Executive Summary
    2.1 Global Eosinophilic Esophagitis Drug Market Size Estimates and Forecasts
        2.1.1 Global Eosinophilic Esophagitis Drug Revenue 2016-2027
        2.1.2 Global Eosinophilic Esophagitis Drug Sales 2016-2027
    2.2 Eosinophilic Esophagitis Drug Market Size by Region: 2021 Versus 2027
    2.3 Eosinophilic Esophagitis Drug Sales by Region (2016-2027)
        2.3.1 Global Eosinophilic Esophagitis Drug Sales by Region: 2016-2021
        2.3.2 Global Eosinophilic Esophagitis Drug Sales Forecast by Region (2022-2027)
        2.3.3 Global Eosinophilic Esophagitis Drug Sales Market Share by Region (2016-2027)
    2.4 Eosinophilic Esophagitis Drug Market Estimates and Projections by Region (2022-2027)
        2.4.1 Global Eosinophilic Esophagitis Drug Revenue by Region: 2016-2021
        2.4.2 Global Eosinophilic Esophagitis Drug Revenue Forecast by Region (2022-2027)
        2.4.3 Global Eosinophilic Esophagitis Drug Revenue Market Share by Region (2016-2027)

3 Global Eosinophilic Esophagitis Drug by Manufacturers
    3.1 Global Top Eosinophilic Esophagitis Drug Manufacturers by Sales
        3.1.1 Global Eosinophilic Esophagitis Drug Sales by Manufacturer (2016-2021)
        3.1.2 Global Eosinophilic Esophagitis Drug Sales Market Share by Manufacturer (2016-2021)
    3.2 Global Top Eosinophilic Esophagitis Drug Manufacturers by Revenue
        3.2.1 Global Eosinophilic Esophagitis Drug Revenue by Manufacturer (2016-2021)
        3.2.2 Global Eosinophilic Esophagitis Drug Revenue Share by Manufacturer (2016-2021)
    3.3 Global Eosinophilic Esophagitis Drug Price by Manufacturer (2016-2021)
    3.4 Competitive Landscape
        3.4.1 Key Eosinophilic Esophagitis Drug Manufacturers Covered: Ranking by Revenue
        3.4.2 Global Eosinophilic Esophagitis Drug Market Concentration Ratio (CR5 and HHI) & (2016-2021)
        3.4.3 Global Eosinophilic Esophagitis Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.5 Global Eosinophilic Esophagitis Drug Manufacturing Base Distribution, Product Type
        3.5.1 Eosinophilic Esophagitis Drug Manufacturers Manufacturing Base Distribution, Headquarters
        3.5.2 Manufacturers Eosinophilic Esophagitis Drug Product Type
        3.5.3 Date of International Manufacturers Enter into Eosinophilic Esophagitis Drug Market
    3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Company Profiles
    4.1 AstraZeneca
        4.1.1 AstraZeneca Corporation Information
        4.1.2 AstraZeneca Description, Business Overview
        4.1.3 AstraZeneca Eosinophilic Esophagitis Drug Products Offered
        4.1.4 AstraZeneca Eosinophilic Esophagitis Drug Sales, Revenue and Gross Margin (2016-2021)
        4.1.5 AstraZeneca Eosinophilic Esophagitis Drug Revenue by Product
        4.1.6 AstraZeneca Eosinophilic Esophagitis Drug Revenue by Application
        4.1.7 AstraZeneca Eosinophilic Esophagitis Drug Revenue by Geographic Area
        4.1.8 AstraZeneca Eosinophilic Esophagitis Drug Revenue by Sales Channel
        4.1.9 AstraZeneca Recent Development
    4.2 GSK
        4.2.1 GSK Corporation Information
        4.2.2 GSK Description, Business Overview
        4.2.3 GSK Eosinophilic Esophagitis Drug Products Offered
        4.2.4 GSK Eosinophilic Esophagitis Drug Sales, Revenue and Gross Margin (2016-2021)
        4.2.5 GSK Eosinophilic Esophagitis Drug Revenue by Product
        4.2.6 GSK Eosinophilic Esophagitis Drug Revenue by Application
        4.2.7 GSK Eosinophilic Esophagitis Drug Revenue by Geographic Area
        4.2.8 GSK Eosinophilic Esophagitis Drug Revenue by Sales Channel
        4.2.9 GSK Recent Development
    4.3 Bayer
        4.3.1 Bayer Corporation Information
        4.3.2 Bayer Description, Business Overview
        4.3.3 Bayer Eosinophilic Esophagitis Drug Products Offered
        4.3.4 Bayer Eosinophilic Esophagitis Drug Sales, Revenue and Gross Margin (2016-2021)
        4.3.5 Bayer Eosinophilic Esophagitis Drug Revenue by Product
        4.3.6 Bayer Eosinophilic Esophagitis Drug Revenue by Application
        4.3.7 Bayer Eosinophilic Esophagitis Drug Revenue by Geographic Area
        4.3.8 Bayer Eosinophilic Esophagitis Drug Revenue by Sales Channel
        4.3.9 Bayer Recent Development
    4.4 Adare Pharmaceuticals
        4.4.1 Adare Pharmaceuticals Corporation Information
        4.4.2 Adare Pharmaceuticals Description, Business Overview
        4.4.3 Adare Pharmaceuticals Eosinophilic Esophagitis Drug Products Offered
        4.4.4 Adare Pharmaceuticals Eosinophilic Esophagitis Drug Sales, Revenue and Gross Margin (2016-2021)
        4.4.5 Adare Pharmaceuticals Eosinophilic Esophagitis Drug Revenue by Product
        4.4.6 Adare Pharmaceuticals Eosinophilic Esophagitis Drug Revenue by Application
        4.4.7 Adare Pharmaceuticals Eosinophilic Esophagitis Drug Revenue by Geographic Area
        4.4.8 Adare Pharmaceuticals Eosinophilic Esophagitis Drug Revenue by Sales Channel
        4.4.9 Adare Pharmaceuticals Recent Development
    4.5 DBV Technologies
        4.5.1 DBV Technologies Corporation Information
        4.5.2 DBV Technologies Description, Business Overview
        4.5.3 DBV Technologies Eosinophilic Esophagitis Drug Products Offered
        4.5.4 DBV Technologies Eosinophilic Esophagitis Drug Sales, Revenue and Gross Margin (2016-2021)
        4.5.5 DBV Technologies Eosinophilic Esophagitis Drug Revenue by Product
        4.5.6 DBV Technologies Eosinophilic Esophagitis Drug Revenue by Application
        4.5.7 DBV Technologies Eosinophilic Esophagitis Drug Revenue by Geographic Area
        4.5.8 DBV Technologies Eosinophilic Esophagitis Drug Revenue by Sales Channel
        4.5.9 DBV Technologies Recent Development
    4.6 Dr. Falk Pharma
        4.6.1 Dr. Falk Pharma Corporation Information
        4.6.2 Dr. Falk Pharma Description, Business Overview
        4.6.3 Dr. Falk Pharma Eosinophilic Esophagitis Drug Products Offered
        4.6.4 Dr. Falk Pharma Eosinophilic Esophagitis Drug Sales, Revenue and Gross Margin (2016-2021)
        4.6.5 Dr. Falk Pharma Eosinophilic Esophagitis Drug Revenue by Product
        4.6.6 Dr. Falk Pharma Eosinophilic Esophagitis Drug Revenue by Application
        4.6.7 Dr. Falk Pharma Eosinophilic Esophagitis Drug Revenue by Geographic Area
        4.6.8 Dr. Falk Pharma Recent Development
    4.7 Quorum Innovations
        4.7.1 Quorum Innovations Corporation Information
        4.7.2 Quorum Innovations Description, Business Overview
        4.7.3 Quorum Innovations Eosinophilic Esophagitis Drug Products Offered
        4.7.4 Quorum Innovations Eosinophilic Esophagitis Drug Sales, Revenue and Gross Margin (2016-2021)
        4.7.5 Quorum Innovations Eosinophilic Esophagitis Drug Revenue by Product
        4.7.6 Quorum Innovations Eosinophilic Esophagitis Drug Revenue by Application
        4.7.7 Quorum Innovations Eosinophilic Esophagitis Drug Revenue by Geographic Area
        4.7.8 Quorum Innovations Recent Development
    4.8 Takeda
        4.8.1 Takeda Corporation Information
        4.8.2 Takeda Description, Business Overview
        4.8.3 Takeda Eosinophilic Esophagitis Drug Products Offered
        4.8.4 Takeda Eosinophilic Esophagitis Drug Sales, Revenue and Gross Margin (2016-2021)
        4.8.5 Takeda Eosinophilic Esophagitis Drug Revenue by Product
        4.8.6 Takeda Eosinophilic Esophagitis Drug Revenue by Application
        4.8.7 Takeda Eosinophilic Esophagitis Drug Revenue by Geographic Area
        4.8.8 Takeda Recent Development
    4.9 Calypso
        4.9.1 Calypso Corporation Information
        4.9.2 Calypso Description, Business Overview
        4.9.3 Calypso Eosinophilic Esophagitis Drug Products Offered
        4.9.4 Calypso Eosinophilic Esophagitis Drug Sales, Revenue and Gross Margin (2016-2021)
        4.9.5 Calypso Eosinophilic Esophagitis Drug Revenue by Product
        4.9.6 Calypso Eosinophilic Esophagitis Drug Revenue by Application
        4.9.7 Calypso Eosinophilic Esophagitis Drug Revenue by Geographic Area
        4.9.8 Calypso Recent Development
    4.10 Celgene
        4.10.1 Celgene Corporation Information
        4.10.2 Celgene Description, Business Overview
        4.10.3 Celgene Eosinophilic Esophagitis Drug Products Offered
        4.10.4 Celgene Eosinophilic Esophagitis Drug Sales, Revenue and Gross Margin (2016-2021)
        4.10.5 Celgene Eosinophilic Esophagitis Drug Revenue by Product
        4.10.6 Celgene Eosinophilic Esophagitis Drug Revenue by Application
        4.10.7 Celgene Eosinophilic Esophagitis Drug Revenue by Geographic Area
        4.10.8 Celgene Recent Development
    4.11 Regeneron
        4.11.1 Regeneron Corporation Information
        4.11.2 Regeneron Description, Business Overview
        4.11.3 Regeneron Eosinophilic Esophagitis Drug Products Offered
        4.11.4 Regeneron Eosinophilic Esophagitis Drug Sales, Revenue and Gross Margin (2016-2021)
        4.11.5 Regeneron Eosinophilic Esophagitis Drug Revenue by Product
        4.11.6 Regeneron Eosinophilic Esophagitis Drug Revenue by Application
        4.11.7 Regeneron Eosinophilic Esophagitis Drug Revenue by Geographic Area
        4.11.8 Regeneron Recent Development

5 Breakdown Data by Type
    5.1 Global Eosinophilic Esophagitis Drug Sales by Type (2016-2027)
        5.1.1 Global Eosinophilic Esophagitis Drug Sales by Type (2016-2021)
        5.1.2 Global Eosinophilic Esophagitis Drug Sales Forecast by Type (2022-2027)
        5.1.3 Global Eosinophilic Esophagitis Drug Sales Market Share by Type (2016-2027)
    5.2 Global Eosinophilic Esophagitis Drug Revenue Forecast by Type (2016-2027)
        5.2.1 Global Eosinophilic Esophagitis Drug Revenue by Type (2016-2021)
        5.2.2 Global Eosinophilic Esophagitis Drug Revenue Forecast by Type (2022-2027)
        5.2.3 Global Eosinophilic Esophagitis Drug Revenue Market Share by Type (2016-2027)
    5.3 Eosinophilic Esophagitis Drug Average Selling Price (ASP) by Type (2016-2027)

6 Breakdown Data by Application
    6.1 Global Eosinophilic Esophagitis Drug Sales by Application (2016-2027)
        6.1.1 Global Eosinophilic Esophagitis Drug Sales by Application (2016-2021)
        6.1.2 Global Eosinophilic Esophagitis Drug Sales Forecast by Application (2022-2027)
        6.1.3 Global Eosinophilic Esophagitis Drug Sales Market Share by Application (2016-2027)
    6.2 Global Eosinophilic Esophagitis Drug Revenue Forecast by Application (2016-2027)
        6.2.1 Global Eosinophilic Esophagitis Drug Revenue by Application (2016-2021)
        6.2.2 Global Eosinophilic Esophagitis Drug Revenue Forecast by Application (2022-2027)
        6.2.3 Global Eosinophilic Esophagitis Drug Revenue Market Share by Application (2016-2027)
    6.3 Eosinophilic Esophagitis Drug Average Selling Price (ASP) by Application (2016-2027)

7 North America
    7.1 North America Eosinophilic Esophagitis Drug Market Size YoY Growth 2016-2027
    7.2 North America Eosinophilic Esophagitis Drug Market Facts & Figures by Country
        7.2.1 North America Eosinophilic Esophagitis Drug Sales by Country (2016-2027)
        7.2.2 North America Eosinophilic Esophagitis Drug Revenue by Country (2016-2027)
    7.3 North America Eosinophilic Esophagitis Drug Sales by Type
    7.4 North America Eosinophilic Esophagitis Drug Sales by Application

8 Asia-Pacific
    8.1 Asia-Pacific Eosinophilic Esophagitis Drug Market Size YoY Growth 2016-2027
    8.2 Asia-Pacific Eosinophilic Esophagitis Drug Market Facts & Figures by Region
        8.2.1 Asia-Pacific Eosinophilic Esophagitis Drug Sales by Region (2016-2027)
        8.2.2 Asia-Pacific Eosinophilic Esophagitis Drug Revenue by Region (2016-2027)
    8.3 Asia-Pacific Eosinophilic Esophagitis Drug Sales by Type
    8.4 Asia-Pacific Eosinophilic Esophagitis Drug Sales by Application

9 Europe
    9.1 Europe Eosinophilic Esophagitis Drug Market Size YoY Growth 2016-2027
    9.2 Europe Eosinophilic Esophagitis Drug Market Facts & Figures by Country
        9.2.1 Europe Eosinophilic Esophagitis Drug Sales by Country (2016-2027)
        9.2.2 Europe Eosinophilic Esophagitis Drug Revenue by Country (2016-2027)
    9.3 Europe Eosinophilic Esophagitis Drug Sales by Type
    9.4 Europe Eosinophilic Esophagitis Drug Sales by Application

10 Latin America
    10.1 Latin America Eosinophilic Esophagitis Drug Market Size YoY Growth 2016-2027
    10.2 Latin America Eosinophilic Esophagitis Drug Market Facts & Figures by Country
        10.2.1 Latin America Eosinophilic Esophagitis Drug Sales by Country (2016-2027)
        10.2.2 Latin America Eosinophilic Esophagitis Drug Revenue by Country (2016-2027)
    10.3 Latin America Eosinophilic Esophagitis Drug Sales by Type
    10.4 Latin America Eosinophilic Esophagitis Drug Sales by Application

11 Middle East and Africa
    11.1 Middle East and Africa Eosinophilic Esophagitis Drug Market Size YoY Growth 2016-2027
    11.2 Middle East and Africa Eosinophilic Esophagitis Drug Market Facts & Figures by Country
        11.2.1 Middle East and Africa Eosinophilic Esophagitis Drug Sales by Country (2016-2027)
        11.2.2 Middle East and Africa Eosinophilic Esophagitis Drug Revenue by Country (2016-2027)
    11.3 Middle East and Africa Eosinophilic Esophagitis Drug Sales by Type
    11.4 Middle East and Africa Eosinophilic Esophagitis Drug Sales by Application

12 Supply Chain and Sales Channel Analysis
    12.1 Eosinophilic Esophagitis Drug Supply Chain Analysis
    12.2 Eosinophilic Esophagitis Drug Key Raw Materials and Upstream Suppliers
    12.3 Eosinophilic Esophagitis Drug Clients Analysis
    12.4 Eosinophilic Esophagitis Drug Sales Channel and Sales Model Analysis
        12.4.1 Eosinophilic Esophagitis Drug Distribution Channel Analysis: Indirect Sales VS Direct Sales
        12.4.2 Eosinophilic Esophagitis Drug Distribution Channel Analysis: Online Sales VS Offline Sales
        12.4.3 Eosinophilic Esophagitis Drug Distributors

13 Market Dynamics
    13.1 Eosinophilic Esophagitis Drug Market Drivers
    13.2 Eosinophilic Esophagitis Drug Market Opportunities
    13.3 Eosinophilic Esophagitis Drug Market Challenges
    13.4 Eosinophilic Esophagitis Drug Market Restraints
    13.5 Porter’s Five Forces Analysis

14 Research Findings and Conclusion

15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer
List of Tables
    Table 1. Global Eosinophilic Esophagitis Drug Market Size Growth Rate by Type (US$ Million): 2021 VS 2027
    Table 2. Major Manufacturers of Budesonide
    Table 3. Major Manufacturers of Fluticasone
    Table 4. Major Manufacturers of Others
    Table 5. Global Eosinophilic Esophagitis Drug Market Size Growth by Application (US$ Million): 2021 VS 2027
    Table 6. Global Eosinophilic Esophagitis Drug Market Size by Region (US$ Million): 2021 VS 2027
    Table 7. Global Eosinophilic Esophagitis Drug Sales by Region (2016-2021) & (K Units)
    Table 8. Global Eosinophilic Esophagitis Drug Sales Forecast by Region (2022-2027) & (K Units)
    Table 9. Global Eosinophilic Esophagitis Drug Revenue by Region (2016-2021) & (US$ Million)
    Table 10. Global Eosinophilic Esophagitis Drug Revenue Forecast by Region (2022-2027) & (US$ Million)
    Table 11. Global Eosinophilic Esophagitis Drug Sales by Manufacturer (2016-2021) & (K Units)
    Table 12. Global Eosinophilic Esophagitis Drug Sales Share by Manufacturer (2016-2021)
    Table 13. Eosinophilic Esophagitis Drug Revenue by Manufacturer (2016-2021) & (US$ Million)
    Table 14. Eosinophilic Esophagitis Drug Revenue Share by Manufacturer (2016-2021)
    Table 15. Key Manufacturers Eosinophilic Esophagitis Drug Price (2016-2021) & (USD/Unit)
    Table 16. Ranking of Global Top Eosinophilic Esophagitis Drug Manufacturers by Revenue (US$ Million) in 2020
    Table 17. Global Eosinophilic Esophagitis Drug Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
    Table 18. Global Eosinophilic Esophagitis Drug by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Eosinophilic Esophagitis Drug as of 2020)
    Table 19. Eosinophilic Esophagitis Drug Manufacturers Manufacturing Base Distribution and Headquarters
    Table 20. Manufacturers Eosinophilic Esophagitis Drug Product Type
    Table 21. Date of International Manufacturers Enter into Eosinophilic Esophagitis Drug Market
    Table 22. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 23. AstraZeneca Corporation Information
    Table 24. AstraZeneca Description and Business Overview
    Table 25. AstraZeneca Eosinophilic Esophagitis Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 26. AstraZeneca Eosinophilic Esophagitis Drug Product
    Table 27. AstraZeneca Eosinophilic Esophagitis Drug Revenue (US$ Million) and Market Share by Product
    Table 28. AstraZeneca Eosinophilic Esophagitis Drug Revenue (US$ Million) and Market Share by Application
    Table 29. AstraZeneca Eosinophilic Esophagitis Drug Revenue (US$ Million) and Market Share by Geographic Area
    Table 30. AstraZeneca Eosinophilic Esophagitis Drug Revenue (US$ Million) and Market Share by Sales Channel
    Table 31. AstraZeneca Recent Development
    Table 32. GSK Corporation Information
    Table 33. GSK Description and Business Overview
    Table 34. GSK Eosinophilic Esophagitis Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 35. GSK Eosinophilic Esophagitis Drug Product
    Table 36. GSK Eosinophilic Esophagitis Drug Revenue (US$ Million) and Market Share by Product
    Table 37. GSK Eosinophilic Esophagitis Drug Revenue (US$ Million) and Market Share by Application
    Table 38. GSK Eosinophilic Esophagitis Drug Revenue (US$ Million) and Market Share by Geographic Area
    Table 39. GSK Eosinophilic Esophagitis Drug Revenue (US$ Million) and Market Share by Sales Channel
    Table 40. GSK Recent Development
    Table 41. Bayer Corporation Information
    Table 42. Bayer Description and Business Overview
    Table 43. Bayer Eosinophilic Esophagitis Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 44. Bayer Eosinophilic Esophagitis Drug Product
    Table 45. Bayer Eosinophilic Esophagitis Drug Revenue (US$ Million) and Market Share by Product
    Table 46. Bayer Eosinophilic Esophagitis Drug Revenue (US$ Million) and Market Share by Application
    Table 47. Bayer Eosinophilic Esophagitis Drug Revenue (US$ Million) and Market Share by Geographic Area
    Table 48. Bayer Eosinophilic Esophagitis Drug Revenue (US$ Million) and Market Share by Sales Channel
    Table 49. Bayer Recent Development
    Table 50. Adare Pharmaceuticals Corporation Information
    Table 51. Adare Pharmaceuticals Description and Business Overview
    Table 52. Adare Pharmaceuticals Eosinophilic Esophagitis Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 53. Adare Pharmaceuticals Eosinophilic Esophagitis Drug Product
    Table 54. Adare Pharmaceuticals Eosinophilic Esophagitis Drug Revenue (US$ Million) and Market Share by Product
    Table 55. Adare Pharmaceuticals Eosinophilic Esophagitis Drug Revenue (US$ Million) and Market Share by Application
    Table 56. Adare Pharmaceuticals Eosinophilic Esophagitis Drug Revenue (US$ Million) and Market Share by Geographic Area
    Table 57. Adare Pharmaceuticals Eosinophilic Esophagitis Drug Revenue (US$ Million) and Market Share by Sales Channel
    Table 58. Adare Pharmaceuticals Recent Development
    Table 59. DBV Technologies Corporation Information
    Table 60. DBV Technologies Description and Business Overview
    Table 61. DBV Technologies Eosinophilic Esophagitis Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 62. DBV Technologies Eosinophilic Esophagitis Drug Product
    Table 63. DBV Technologies Eosinophilic Esophagitis Drug Revenue (US$ Million) and Market Share by Product
    Table 64. DBV Technologies Eosinophilic Esophagitis Drug Revenue (US$ Million) and Market Share by Application
    Table 65. DBV Technologies Eosinophilic Esophagitis Drug Revenue (US$ Million) and Market Share by Geographic Area
    Table 66. DBV Technologies Eosinophilic Esophagitis Drug Revenue (US$ Million) and Market Share by Sales Channel
    Table 67. DBV Technologies Recent Development
    Table 68. Dr. Falk Pharma Corporation Information
    Table 69. Dr. Falk Pharma Description and Business Overview
    Table 70. Dr. Falk Pharma Eosinophilic Esophagitis Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 71. Dr. Falk Pharma Eosinophilic Esophagitis Drug Product
    Table 72. Dr. Falk Pharma Eosinophilic Esophagitis Drug Revenue (US$ Million) and Market Share by Product
    Table 73. Dr. Falk Pharma Eosinophilic Esophagitis Drug Revenue (US$ Million) and Market Share by Application
    Table 74. Dr. Falk Pharma Eosinophilic Esophagitis Drug Revenue (US$ Million) and Market Share by Geographic Area
    Table 75. Dr. Falk Pharma Recent Development
    Table 76. Quorum Innovations Corporation Information
    Table 77. Quorum Innovations Description and Business Overview
    Table 78. Quorum Innovations Eosinophilic Esophagitis Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 79. Quorum Innovations Eosinophilic Esophagitis Drug Product
    Table 80. Quorum Innovations Eosinophilic Esophagitis Drug Revenue (US$ Million) and Market Share by Product
    Table 81. Quorum Innovations Eosinophilic Esophagitis Drug Revenue (US$ Million) and Market Share by Application
    Table 82. Quorum Innovations Eosinophilic Esophagitis Drug Revenue (US$ Million) and Market Share by Geographic Area
    Table 83. Quorum Innovations Recent Development
    Table 84. Takeda Corporation Information
    Table 85. Takeda Description and Business Overview
    Table 86. Takeda Eosinophilic Esophagitis Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 87. Takeda Eosinophilic Esophagitis Drug Product
    Table 88. Takeda Eosinophilic Esophagitis Drug Revenue (US$ Million) and Market Share by Product
    Table 89. Takeda Eosinophilic Esophagitis Drug Revenue (US$ Million) and Market Share by Application
    Table 90. Takeda Eosinophilic Esophagitis Drug Revenue (US$ Million) and Market Share by Geographic Area
    Table 91. Takeda Recent Development
    Table 92. Calypso Corporation Information
    Table 93. Calypso Description and Business Overview
    Table 94. Calypso Eosinophilic Esophagitis Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 95. Calypso Eosinophilic Esophagitis Drug Product
    Table 96. Calypso Eosinophilic Esophagitis Drug Revenue (US$ Million) and Market Share by Product
    Table 97. Calypso Eosinophilic Esophagitis Drug Revenue (US$ Million) and Market Share by Application
    Table 98. Calypso Eosinophilic Esophagitis Drug Revenue (US$ Million) and Market Share by Geographic Area
    Table 99. Calypso Recent Development
    Table 100. Celgene Corporation Information
    Table 101. Celgene Description and Business Overview
    Table 102. Celgene Eosinophilic Esophagitis Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 103. Celgene Eosinophilic Esophagitis Drug Product
    Table 104. Celgene Eosinophilic Esophagitis Drug Revenue (US$ Million) and Market Share by Product
    Table 105. Celgene Eosinophilic Esophagitis Drug Revenue (US$ Million) and Market Share by Application
    Table 106. Celgene Eosinophilic Esophagitis Drug Revenue (US$ Million) and Market Share by Geographic Area
    Table 107. Celgene Recent Development
    Table 108. Regeneron Corporation Information
    Table 109. Regeneron Description and Business Overview
    Table 110. Regeneron Eosinophilic Esophagitis Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 111. Regeneron Eosinophilic Esophagitis Drug Product
    Table 112. Regeneron Eosinophilic Esophagitis Drug Revenue (US$ Million) and Market Share by Product
    Table 113. Regeneron Eosinophilic Esophagitis Drug Revenue (US$ Million) and Market Share by Application
    Table 114. Regeneron Eosinophilic Esophagitis Drug Revenue (US$ Million) and Market Share by Geographic Area
    Table 115. Regeneron Recent Development
    Table 116. Global Eosinophilic Esophagitis Drug Sales by Type (2016-2021) & (K Units)
    Table 117. Global Eosinophilic Esophagitis Drug Sales Forecast by Type (2022-2027) & (K Units)
    Table 118. Global Eosinophilic Esophagitis Drug Revenue by Type (2016-2021) & (US$ Million)
    Table 119. Global Eosinophilic Esophagitis Drug Revenue Forecast by Type (2022-2027) & (US$ Million)
    Table 120. Global Eosinophilic Esophagitis Drug Sales by Application (2016-2021) & (K Units)
    Table 121. Global Eosinophilic Esophagitis Drug Sales Forecast by Application (2022-2027) & (K Units)
    Table 122. Global Eosinophilic Esophagitis Drug Revenue by Application (2016-2021) & (US$ Million)
    Table 123. Global Eosinophilic Esophagitis Drug Revenue Forecast by Application (2022-2027) & (US$ Million)
    Table 124. North America Eosinophilic Esophagitis Drug Sales by Country (2016-2021) & (K Units)
    Table 125. North America Eosinophilic Esophagitis Drug Sales by Country (2022-2027) & (K Units)
    Table 126. North America Eosinophilic Esophagitis Drug Revenue by Country (2016-2021) & (US$ Million)
    Table 127. North America Eosinophilic Esophagitis Drug Revenue by Country (2022-2027) & (US$ Million)
    Table 128. North America Eosinophilic Esophagitis Drug Sales by Type (2016-2021) & (K Units)
    Table 129. North America Eosinophilic Esophagitis Drug Sales by Application (2016-2021) & (K Units)
    Table 130. Asia-Pacific Eosinophilic Esophagitis Drug Sales by Region (2016-2021) & (K Units)
    Table 131. Asia-Pacific Eosinophilic Esophagitis Drug Sales by Region (2022-2027) & (K Units)
    Table 132. Asia-Pacific Eosinophilic Esophagitis Drug Revenue by Region (2016-2027) & (US$ Million)
    Table 133. Asia-Pacific Eosinophilic Esophagitis Drug Revenue by Region (2022-2027) & (US$ Million)
    Table 134. Asia-Pacific Eosinophilic Esophagitis Drug Sales by Type (2016-2021) & (K Units)
    Table 135. Asia-Pacific Eosinophilic Esophagitis Drug Sales by Application (2016-2021) & (K Units)
    Table 136. Europe Eosinophilic Esophagitis Drug Sales by Country (2016-2021) & (K Units)
    Table 137. Europe Eosinophilic Esophagitis Drug Sales by Country (2022-2027) & (K Units)
    Table 138. Europe Eosinophilic Esophagitis Drug Revenue by Country (2016-2021) & (US$ Million)
    Table 139. Europe Eosinophilic Esophagitis Drug Revenue by Country (2022-2027) & (US$ Million)
    Table 140. Europe Eosinophilic Esophagitis Drug Sales by Type (2016-2021) & (K Units)
    Table 141. Europe Eosinophilic Esophagitis Drug Sales by Application (2016-2021) & (K Units)
    Table 142. Latin America Eosinophilic Esophagitis Drug Sales by Country (2016-2021) & (K Units)
    Table 143. Latin America Eosinophilic Esophagitis Drug Sales by Country (2022-2027) & (K Units)
    Table 144. Latin America Eosinophilic Esophagitis Drug Revenue by Country (2016-2021) & (US$ Million)
    Table 145. Latin America Eosinophilic Esophagitis Drug Revenue by Country (2022-2027) & (US$ Million)
    Table 146. Latin America Eosinophilic Esophagitis Drug Sales by Type (2016-2021) & (K Units)
    Table 147. Latin America Eosinophilic Esophagitis Drug Sales by Application (2016-2021) & (K Units)
    Table 148. Middle East and Africa Eosinophilic Esophagitis Drug Sales by Country (2016-2021) & (K Units)
    Table 149. Middle East and Africa Eosinophilic Esophagitis Drug Sales by Country (2022-2027) & (K Units)
    Table 150. Middle East and Africa Eosinophilic Esophagitis Drug Revenue by Country (2016-2021) & (US$ Million)
    Table 151. Middle East and Africa Eosinophilic Esophagitis Drug Revenue by Country (2022-2027) & (US$ Million)
    Table 152. Middle East and Africa Eosinophilic Esophagitis Drug Sales by Type (2016-2021) & (K Units)
    Table 153. Middle East and Africa Eosinophilic Esophagitis Drug Sales by Application (2016-2021) & (K Units)
    Table 154. Eosinophilic Esophagitis Drug Key Raw Materials, Industry Status and Trend
    Table 155. Eosinophilic Esophagitis Drug Key Raw Materials and Upstream Suppliers
    Table 156. Eosinophilic Esophagitis Drug Clients Status and Trend
    Table 157. Eosinophilic Esophagitis Drug Typical Clients
    Table 158. Eosinophilic Esophagitis Drug Distributors
    Table 159. Key Drivers: Impact Analysis (2022-2027)
    Table 160. Eosinophilic Esophagitis Drug Market Drivers
    Table 161. Eosinophilic Esophagitis Drug Market Opportunities
    Table 162. Eosinophilic Esophagitis Drug Market Challenges
    Table 163. Eosinophilic Esophagitis Drug Market Restraints
    Table 164. Eosinophilic Esophagitis Drug Porter’s Five Forces Analysis
    Table 165. Research Programs/Design for This Report
    Table 166. Key Data Information from Secondary Sources
    Table 167. Key Data Information from Primary Sources
List of Figures
    Figure 1. Eosinophilic Esophagitis Drug Product Picture
    Figure 2. Global Eosinophilic Esophagitis Drug Sales Market Share by Type in 2021 & 2027
    Figure 3. Budesonide Product Picture
    Figure 4. Fluticasone Product Picture
    Figure 5. Others Product Picture
    Figure 6. Global Eosinophilic Esophagitis Drug Sales Market Share by Application in 2021 & 2027
    Figure 7. Hospitals Examples
    Figure 8. Clinics Examples
    Figure 9. Drugstore Examples
    Figure 10. Eosinophilic Esophagitis Drug Report Years Considered
    Figure 11. Global Eosinophilic Esophagitis Drug Market Size, (US$ Million), 2016 VS 2021 VS 2027
    Figure 12. Global Eosinophilic Esophagitis Drug Market Size 2016-2027 (US$ Million)
    Figure 13. Global Eosinophilic Esophagitis Drug Sales 2016-2027 (K Units)
    Figure 14. Global Eosinophilic Esophagitis Drug Market Size Market Share by Region: 2021 Versus 2027
    Figure 15. Global Eosinophilic Esophagitis Drug Sales Market Share Forecast by Region (2016-2027)
    Figure 16. Global Eosinophilic Esophagitis Drug Revenue Market Share by Region (2016-2027)
    Figure 17. Global Eosinophilic Esophagitis Drug Sales Share by Manufacturer in 2020
    Figure 18. Eosinophilic Esophagitis Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
    Figure 19. Global Eosinophilic Esophagitis Drug Sales Market Share Forecast by Type (2016-2027)
    Figure 20. Global Eosinophilic Esophagitis Drug Revenue Market Share Forecast by Type (2016-2027)
    Figure 21. Eosinophilic Esophagitis Drug Average Selling Price (ASP) by Type (2016-2021) & (USD/Unit)
    Figure 22. Global Eosinophilic Esophagitis Drug Sales Market Share Forecast by Application (2016-2027)
    Figure 23. Global Eosinophilic Esophagitis Drug Revenue Market Share Forecast by Application (2016-2027)
    Figure 24. Eosinophilic Esophagitis Drug Average Selling Price (ASP) by Application (2016-2021) & (USD/Unit)
    Figure 25. North America Eosinophilic Esophagitis Drug Revenue 2016-2027 (US$ Million)
    Figure 26. North America Eosinophilic Esophagitis Drug Sales Market Share by Type (2016-2021)
    Figure 27. North America Eosinophilic Esophagitis Drug Sales Market Share by Application (2016-2021)
    Figure 28. Asia-Pacific Eosinophilic Esophagitis Drug Revenue 2016-2027 (US$ Million)
    Figure 29. Asia-Pacific Eosinophilic Esophagitis Drug Sales Market Share by Region (2016-2027)
    Figure 30. Asia-Pacific Eosinophilic Esophagitis Drug Revenue Market Share by Region (2016-2027)
    Figure 31. Asia-Pacific Eosinophilic Esophagitis Drug Sales Market Share by Type (2016-2021)
    Figure 32. Asia-Pacific Eosinophilic Esophagitis Drug Sales Market Share by Application (2016-2021)
    Figure 33. Europe Eosinophilic Esophagitis Drug Revenue Growth Rate 2016-2027 (US$ Million)
    Figure 34. Europe Eosinophilic Esophagitis Drug Sales Market Share by Country (2016-2027)
    Figure 35. Europe Eosinophilic Esophagitis Drug Revenue Market Share by Country (2016-2027)
    Figure 36. Europe Eosinophilic Esophagitis Drug Sales Market Share by Type (2016-2021)
    Figure 37. Europe Eosinophilic Esophagitis Drug Sales Market Share by Application (2016-2021)
    Figure 38. Latin America Eosinophilic Esophagitis Drug Revenue Growth Rate 2016-2027 (US$ Million)
    Figure 39. Latin America Eosinophilic Esophagitis Drug Sales Market Share by Country (2016-2027)
    Figure 40. Latin America Eosinophilic Esophagitis Drug Revenue Market Share by Country (2016-2021)
    Figure 41. Latin America Eosinophilic Esophagitis Drug Sales Market Share by Type (2016-2021)
    Figure 42. Latin America Eosinophilic Esophagitis Drug Sales Market Share by Application (2016-2021)
    Figure 43. Middle East and Africa Eosinophilic Esophagitis Drug Revenue Growth Rate 2016-2027 (US$ Million)
    Figure 44. Middle East and Africa Eosinophilic Esophagitis Drug Sales Market Share by Country (2016-2027)
    Figure 45. Middle East and Africa Eosinophilic Esophagitis Drug Revenue Market Share by Country (2016-2027)
    Figure 46. Middle East and Africa Eosinophilic Esophagitis Drug Sales Market Share by Type (2016-2021)
    Figure 47. Middle East and Africa Eosinophilic Esophagitis Drug Sales Market Share by Application (2016-2021)
    Figure 48. Eosinophilic Esophagitis Drug Supply Chain (Upstream and Downstream Market)
    Figure 49. Global Production Market Share of Eosinophilic Esophagitis Drug Raw Materials by Region in 2020
    Figure 50. Eosinophilic Esophagitis Drug Distribution Channels
    Figure 51. Global Eosinophilic Esophagitis Drug Percentage 2016-2027: Indirect Sales VS Direct Sales
    Figure 52. Global Eosinophilic Esophagitis Drug Percentage 2016-2027: Online Sales VS Offline Sales
    Figure 53. Porter's Five Forces Analysis
    Figure 54. Bottom-up and Top-down Approaches for This Report
    Figure 55. Data Triangulation
    Figure 56. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
AstraZeneca
GSK
Bayer
Adare Pharmaceuticals
DBV Technologies
Dr. Falk Pharma
Quorum Innovations
Takeda
Calypso
Celgene
Regeneron
Frequently Asked Questions
Eosinophilic Esophagitis Drug report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Eosinophilic Esophagitis Drug report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Eosinophilic Esophagitis Drug report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Aircraft Carpets

This report studies the Aircraft Carpet market. The local pressure of high heels would punch a ho ... Read More